Author:
Demircan Yalçın Yağmur,Töral Taylan Berkin,Sukas Sertan,Yıldırım Ender,Zorlu Özge,Gündüz Ufuk,Külah Haluk
Abstract
AbstractWe report the development of a lab-on-a-chip system, that facilitates coupled dielectrophoretic detection (DEP-D) and impedimetric counting (IM-C), for investigating drug resistance in K562 and CCRF-CEM leukemia cells without (immuno) labeling. Two IM-C units were placed upstream and downstream of the DEP-D unit for enumeration, respectively, before and after the cells were treated in DEP-D unit, where the difference in cell count gave the total number of trapped cells based on their DEP characteristics. Conductivity of the running buffer was matched the conductivity of cytoplasm of wild type K562 and CCRF-CEM cells. Results showed that DEP responses of drug resistant and wild type K562 cells were statistically discriminative (at p = 0.05 level) at 200 mS/m buffer conductivity and at 8.6 MHz working frequency of DEP-D unit. For CCRF-CEM cells, conductivity and frequency values were 160 mS/m and 6.2 MHz, respectively. Our approach enabled discrimination of resistant cells in a group by setting up a threshold provided by the conductivity of running buffer. Subsequent selection of drug resistant cells can be applied to investigate variations in gene expressions and occurrence of mutations related to drug resistance.
Funder
The Scientific and Technological Research Council of Turkey
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Bar-Zeev, M., Livney, Y. D. & Assaraf, Y. G. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance. Drug Resist. Update 31, 15–30 (2017).
2. Cui, Q. et al. Modulating ROS to overcome multidrug resistance in cancer. Drug Resist. Update 41, 1–25 (2018).
3. Baguley, B. C. Multi-drug resistance in cancer. In Multi-Drug Resistance in Cancer (ed. Zhou, J.) 1–14 (Humana Press, 2010).
4. Cao, X., Hou, J., An, Q., Assaraf, Y. G. & Wang, X. Towards the overcoming of anticancer drug resistance mediated by p53 mutations. Drug Resist. Update 49, 100671 (2020).
5. Bukowski, K., Kciuk, M. & Kontek, R. Mechanisms of multidrug resistance in cancer chemotherapy. Int. J. Mol. Sci. 21, 3233 (2020).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献